Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
Sign Up to like & getrecommendations! Published in 2021 at "AIDS patient care and STDs"
DOI: 10.1089/apc.2021.0033
Abstract: Safety differences between tenofovir alafenamide/emtricitabine (TAF) and tenofovir disoproxil fumarate/emtricitabine (TDF/FTC)-formulated pre-exposure prophylaxis (PrEP) appear to have little clinical significance for most PrEP users. Furthermore, generic TDF-formulated PrEP is projected to decrease the price of… read more here.
Keywords: prep; alafenamide emtricitabine; tenofovir disoproxil; descovy ... See more keywords